Our Mission

Revolutionize Cancer Screening

Early detection of cancer improves survival and lowers medical costs. MiRXES is committed to enable cancer detection at asymptomatic and actionable stage through blood based screening. MiRXES leverages an ultra-sensitive qPCR technology to detect blood borne miRNA cancer markers to deliver the solution.


Read More
image

Collaborate
with Us

MiRXES welcomes collaboration in clinical validation of cancer miRNA assays

Contact Us

Use
Our Technology

We empower miRNA research with tailored products and services

Read More

Join
Our Team

We seek passionate and committed individuals to realize our vision

Hiring Now

Invest
in MiRXES

MiRXES Welcomes investors and strategic partners to accelerate growth

Read More

Our

Products and Services